The brain appears to remember immune responses, and memories can trigger them to happen again.
This might explain some psychosomatic illnesses.
Microdosing Research- Mixed Results
This article breaks down the current trend of microdosing, and the lack of solid research.
Read moreRisks of Psychedelics
Before psychedelic therapy and services becomes widely available, there needs to be a better understanding of all the ways these experiences can go wrong.
Read moreRecordings from the NIH Psychedelics Conference
The NIH Workshop on Psychedelics as Therapeutics was conducted by the National Institute of Mental Health, the National Institute on Drug Abuse, and the National Institute on Alcohol Abuse and Alcoholism.
Read morePsilocybin for Depression Is Effective for One Year
New research shows that psilocybin treatment for major depression is effective for up to a year for most patients.
Read moreIV Ketamine for Depression
New research shows that Ketamine intravenous therapy improves depression and reduces suicidal ideation.
Read moreKetamine for Suicidal Thoughts
A new study shows that Ketamine effectively silences suicidal thoughts, especially in bipolar patients.
The effects wore off after 4-6 weeks however.
Read moreDMT and Depression
The first clinical trial using DMT for depression has promising results.
Read morePsychedelics and Art
In a conversation with Chris Wink, co-founder of Blue Man Group and creator of the psychedelic art exhibit Wink World, he discusses the nature of play and how it relates to art, life, and the psychedelic renaissance.
Read moreFalse Insights
More Research on Psychedelics
Here’s a look at the most recent, promising research on psychedelics and mental health.
Read more